Open Access Open Access  Restricted Access Subscription Access

The Impact of Rotavirus Vaccination on the Diarrhea Admission and Mortality Rate in Children at WMTHC, Gezira State, Sudan


Affiliations
1 Center of Bioscience and Biotechnology, Gezira University, P.O.Box 20 Wad Madani, Sudan
2 Deparment of Pharmacology, Gezira University, P.O.Box 20 Wad Madani, Sudan
 

A prospective study was conducted at Wad Madani Teaching Hospital for Children (WMTHC), among children below the age of five years. All the children included in this study were admitted with diarrheal disease in the period between January 2011-May 2012.The main objective of this research was to study the impact of rotavirus vaccination on the rate of diarrhea admission andmortality among children. The study population was checked for rotavirus vaccination status (rotavirus vaccine), stool samples were examined for rotavirus in the hospital laboratory, and children with other illness causing diarrhea were excluded from the study. The study was divided in to three phases each of six months period, phase one six months before the implementation of the vaccine included 249 child, phase two six months after the implementation included 304 child and phase three another six months post the vaccine implementation included 120 child, according to the total number admitted during the period of the study. The total number of vaccinated children increased significantly (P.value =0.000) from the first year of vaccine adoption (7.2% to 47.5%), and the majority of vaccinated children were below six months of age. Slight decline in diarrhea related mortality was noticed after the introduction of rotavirus vaccination (from 9.6% to 7%) , while, an increase was noticed on the rate of diarrhea hospital admission(600.4 to 643.6) ,but, no significant differences (P.value = 0.71355197) was noticed between the rate of admissions or deaths in regard to the known rotavirus seasonality in Sudan pre-and after the implementation of the vaccine. A significant difference (P.value =0.000) was observed of rotavirus detection between the first post-vaccine adoption period and the prevaccination period, although, no significant was noticed among the two periods of vaccine adoption.

Keywords

Rotavirus, Vaccine, Diarrhea, Children, Sudan, WMTHC.
User
Notifications
Font Size

  • Bishop, R. F., Davidson, G. P., Holmes, I. H. and Ruck, B. J. (1973). Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet, 2, 128 1
  • Dennehy PH .(2000). "Transmission of rotavirus and other enteric pathogens in the home". Pediatr. Infect. Dis. J. 19 (10 Suppl): S103–5. doi:10.1097/00006454200010001-00003. PMID 11052397.
  • Grimwood K, Lambert SB . (2009). "Rotavirus vaccines: opportunities and challenges". Human Vaccines 5 (2): 57–69. doi:10.4161/hv.5.2.6924. PMID 18838873. http://www.landesbioscience.com/journals/hv/abstract.php?id=6924
  • Cunliffe, N. A., and Nakagomi.O (2005). A critical time for rotavirus vaccines: a review. Expert Rev. Vaccines 4:521-532.
  • Dennehy PH .(2008). "Rotavirus vaccines: an overview". Clin. Microbiol. Rev. 21 (1): 198–208. doi:10.1128/CMR.00029-07. PMC 2223838. PMID 18202442.
  • http://cmr.asm.org/cgi/content/full/21/1/198?view=long&pmid=18202442.
  • Kuzuya M, Fujii R, Hamano M, Nishijima M, Ogura H (2007). Detection and molecular characterization of human group C Rotaviruses in Okayama Prefecture, Japan, between 1986 and 2005. J Med Virol 79: 1219-1228.
  • O'Ryan M .(2007). "Rotarix (RIX4414): an oral human rotavirus vaccine". Expert review of vaccines 6 (1): 11–9. doi:10.1586/14760584.6.1.11. PMID 17280473.
  • Matson DO .(2006). "The pentavalent rotavirus vaccine, RotaTeq". Seminars in paediatric infectious diseases 17 (4): 195–9. doi:10.1053/j.spid.2006.08.005. PMID 17055370.
  • Ward RL, Clark HF, Offit PA . (2010). "Influence of potential protective mechanisms on the development of live rotavirus vaccines". The Journal of Infectious Diseases 202 (Suppl): S72–9. doi:10.1086/653549. PMID 20684721.http://www.jid.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=206 84721.
  • World Health Organization-Report.(2011) The introduction of life-saving rotavirus vaccine in Sudan. 18 July .
  • Salinas B, González G, González R, Escalona M, Materán M, Schael IP. (2004) Epidemiologic and clinical characteristics of rotavirus disease during five years of surveillance in Venezuela. Pediatr Infect Dis J. Oct;23(10 Suppl):S161-7.
  • Nokes DJ, Abwao J, Pamba A, Peenze I, Dewar J, Maghenda JK, Gatakaa H, Bauni E,Scott JA, Maitland K, Williams TN.(2008) Incidence and clinical characteristics of group A rotavirus infections among children admitted to hospital in Kilifi, Kenya. PLoS Med ; 5:e153.
  • do Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, Giaquinto C, Dominiak-Felden G, Van Damme P, Myint TT, Maldonado YA, Spoulou Gladstone BP et al. (2011) Protective effect of natural rotavirus infection in an Indian birth cohort. New England Journal of Medicine, ;365:337-346.

Abstract Views: 224

PDF Views: 89




  • The Impact of Rotavirus Vaccination on the Diarrhea Admission and Mortality Rate in Children at WMTHC, Gezira State, Sudan

Abstract Views: 224  |  PDF Views: 89

Authors

Mai Abdalla Ali
Center of Bioscience and Biotechnology, Gezira University, P.O.Box 20 Wad Madani, Sudan
Fatima Kamal
Center of Bioscience and Biotechnology, Gezira University, P.O.Box 20 Wad Madani, Sudan
Imad Taj Eldin Mohamed
Deparment of Pharmacology, Gezira University, P.O.Box 20 Wad Madani, Sudan
Siddig Ahmed Gibril Rahoud
Center of Bioscience and Biotechnology, Gezira University, P.O.Box 20 Wad Madani, Sudan

Abstract


A prospective study was conducted at Wad Madani Teaching Hospital for Children (WMTHC), among children below the age of five years. All the children included in this study were admitted with diarrheal disease in the period between January 2011-May 2012.The main objective of this research was to study the impact of rotavirus vaccination on the rate of diarrhea admission andmortality among children. The study population was checked for rotavirus vaccination status (rotavirus vaccine), stool samples were examined for rotavirus in the hospital laboratory, and children with other illness causing diarrhea were excluded from the study. The study was divided in to three phases each of six months period, phase one six months before the implementation of the vaccine included 249 child, phase two six months after the implementation included 304 child and phase three another six months post the vaccine implementation included 120 child, according to the total number admitted during the period of the study. The total number of vaccinated children increased significantly (P.value =0.000) from the first year of vaccine adoption (7.2% to 47.5%), and the majority of vaccinated children were below six months of age. Slight decline in diarrhea related mortality was noticed after the introduction of rotavirus vaccination (from 9.6% to 7%) , while, an increase was noticed on the rate of diarrhea hospital admission(600.4 to 643.6) ,but, no significant differences (P.value = 0.71355197) was noticed between the rate of admissions or deaths in regard to the known rotavirus seasonality in Sudan pre-and after the implementation of the vaccine. A significant difference (P.value =0.000) was observed of rotavirus detection between the first post-vaccine adoption period and the prevaccination period, although, no significant was noticed among the two periods of vaccine adoption.

Keywords


Rotavirus, Vaccine, Diarrhea, Children, Sudan, WMTHC.

References